[DOI] [PMC free article] [PubMed] [Google Scholar] 40.Seino Y, Terauchi Y, Osonoi T, et al
Lose up to 20% of your bodyweight supported by personalized medical care for safe, effective, and sustainable results
In practical terms, that means: Before starting treatment: You will need to show that you are actively participating in an intensive behavioral therapy (IBT) program While on the medication: You will need to continue that participation For approval: Carriers will use prior authorization to verify both This formalizes something that was already happening in some plans, but raises the bar and makes it a more consistent expectation across FEHB carriers
the identification of transitional cell carcinoma in situ in urethral epithelium or the history of a previous bladder cancer facilitates the diagnosis
Consult with your healthcare provider to see if this innovative treatment is right for you and take the first step towards a healthier future today
A benefit exclusion cannot be resolved through a PA or medical-necessity appeal